Abstract An 11-year-old girl was found to have pale complexion and anemia with gradual aggravation for one year. She was weak in the past and developed pneumonia in the right middle lung 3-5 times per year, which was improved after anti-infective therapy. She and her mother had congenital deaf-mutism. Physical examination showed the appearance of anemia, without bleeding, jaundice, hepatosplenomegaly, or lymph node enlargement. Routine blood test results showed reductions in all three blood cell lines, normocytic anemia, and megaloblastoid change in granulocytic and erythroid cell lines in bone marrow, with no obvious increase in primitive cells or metastatic tumor cells. Whole exome sequencing indicated the presence of a known pathogenic mutation for Emberger syndrome (ES), c.1084C > T (p.Arg362*) in the GATA2 gene. The girl was finally diagnosed with ES, and myelodysplastic syndrome (MDS) progressed to acute myeloid leukemia during follow-up. ES is a rare type of MDS with autosomal dominant inheritance in clinical practice, and it is difficult to make a confirmed diagnosis. ES should be considered for children with unexplained lymphedema and congenital deafness, and gene detection should be performed to make a confirmed diagnosis.
CHEN Ling-Ling,HE Xiang-Ling,CHEN Ke-Ke. Congenital deaf-mutism with pale complexion and anemia for 1 year in a school-aged girl[J]. CJCP, 2019, 21(11): 1105-1109.
CHEN Ling-Ling,HE Xiang-Ling,CHEN Ke-Ke. Congenital deaf-mutism with pale complexion and anemia for 1 year in a school-aged girl[J]. CJCP, 2019, 21(11): 1105-1109.
Saida S, Umeda K, Yasumi T, et al. Successful reducedintensity stem cell transplantation for GATA2 deficiency before progression of advanced MDS[J]. Pediatr Transplant, 2016, 20(2):333-336.
[2]
Nováková M, Žaliová M, Suková M, et al. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome[J]. Haematologica, 2016, 101(6):707-716.
[3]
Emberger JM, Navarro M, Dejean M, et al. Deaf-mutism, lymphedema of the lower limbs and hematological abnormalities (acute leukemia, cytopenia) with autosomal dominant transmission[J]. J Genet Hum, 1979, 27(3):237-245.
[4]
Rakhmanov Y, Maltese PE, Paolacci S, et al. Genetic testing for Emberger syndrome[J]. EuroBiotech J, 2018, 2:19-21.
[5]
Hsu AP, Sampaio EP, Khan J, et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome[J]. Blood, 2011, 118(10):2653-2655.
[6]
Zawawi F, Sokolov M, Mawby T, et al. Emberger syndrome:a rare association with hearing loss[J]. Int J Pediatr Otorhinolaryngol, 2018, 108:82-84.
[7]
Michelini S, Cardone M, Haag M, et al. A rare case of Emberger syndrome caused by a de novo mutation in the GATA2 gene[J]. Lymphology, 2016, 49(1):15-20.
[8]
Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency:a protean disorder of hematopoiesis, lymphatics, and immunity[J]. Blood, 2014, 123(6):809-821.
[9]
Mutsaers PG, van de Loosdrecht AA, Tawana K, et al. Highly variable clinical manifestations in a large family with a novel GATA2 mutation[J]. Leukemia, 2013, 27(11):2247-2248.
[10]
Brambila-Tapia AJL, García-Ortiz JE, Brouillard P, et al. GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome[J]. Hematology, 2017, 22(8):467-471.
[11]
Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)[J]. Nat Genet, 2011, 43(10):929-931.
[12]
Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia[J]. Nat Genet, 2011, 43(10):1012-1017.
[13]
Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency[J]. Blood, 2011, 118(10):2656-2658.
[14]
Saste AB, Jiang F, Arias-Stella J, et al. Emberger syndrome with concomitant GATA2, NPM1 and FLT3-ITD mutations in remission after allogeneic stem cell transplant[J]. Biol Blood Marrow Tr, 2016, 22(3):S208-S209.
[15]
Rastogi N, Abraham RS, Chadha R, et al. Successful nonmyeloablative allogeneic stem cell transplant in a child with Emberger syndrome and GATA2 mutation[J]. J Pediatr Hematol Oncol, 2018, 40(6):e383-e388.
[16]
Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency[J]. Blood, 2011, 118(13):3715-3720.
